BofA Securities analyst Greg Harrison, while lowering the price target to $39 from $43, reiterated a Buy rating, noting the potential overhang on safety until more data becomes available.

BofA Securities analyst Greg Harrison, while lowering the price target to $39 from $43, reiterated a Buy rating, noting the potential overhang on safety until more data becomes available. H.C.

The door opened for the Cubs, Dodgers, Phillies and Yankees to make their case for the No. 1 spot in this week's MLB power ...

On Thursday, BofA Securities analyst Greg Harrison adjusted the price target for Intellia Therapeutics (NASDAQ: NTLA) stock, reducing it to $39.00 from the previous $43.00, while still holding a Buy ...

On Wednesday, BofA Securities analyst Greg Harrison adjusted the price target for Rocket Pharmaceuticals (NASDAQ: RCKT), slashing it significantly to $9.00 from the previous target of $32.00.The stock ...

On Wednesday, BofA Securities analyst Greg Harrison adjusted the price target for Rocket Pharmaceuticals (NASDAQ: RCKT), slashing it significantly to $9.00 from the previous target of $32.00.

Pima College has promoted jumps coach Chad Harrison to interim head coach in the wake of Greg Wenneborg's February firing. The Aztecs announced the move Wednesday. Harrison has been with the ...

During the last three months, 12 analysts shared their evaluations of Liquidia LQDA, revealing diverse outlooks from bullish to bearish. The following table encapsulates their recent ratings ...